|
Stern, Howard M; Gardner, Humphrey; Burzykowski, Tomasz et al. (2015) PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance. Clin Cancer Res 21:2065-74
|
|
Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas et al. (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365:1273-83
|
|
Press, Michael F; Sauter, Guido; Buyse, Marc et al. (2011) Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy. J Clin Oncol 29:859-67
|
|
Ma, Huiyan; Wang, Yaping; Sullivan-Halley, Jane et al. (2010) Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res 70:575-87
|
|
Ma, Huiyan; Wang, Yaping; Sullivan-Halley, Jane et al. (2009) Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev 18:2214-20
|
|
Press, Michael F; Sauter, Guido; Bernstein, Leslie et al. (2005) Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res 11:6598-607
|
|
Agus, David B; Gordon, Michael S; Taylor, Charles et al. (2005) Phase I clinical study of pertuzumab, a novel HER dimerization inhibitor, in patients with advanced cancer. J Clin Oncol 23:2534-43
|
|
Mass, Robert D; Press, Michael F; Anderson, Steven et al. (2005) Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. Clin Breast Cancer 6:240-6
|
|
Dybdal, Noel; Leiberman, Grazyna; Anderson, Steven et al. (2005) Determination of HER2 gene amplification by fluorescence in situ hybridization and concordance with the clinical trials immunohistochemical assay in women with metastatic breast cancer evaluated for treatment with trastuzumab. Breast Cancer Res Treat 93:3-11
|
|
Saffari, B; Bernstein, L; Hong, D C et al. (2005) Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer 15:952-63
|
Showing the most recent 10 out of 43 publications
